Qkine has closed an oversubscribed funding round after raising more than £4million to help it scale its manufacturing, R&D and commercial functions and relocate to a new state-of-the-art facility in Cambridge
The Cambridge Science Park company, which expects to more than treble its headcount in the next three years, manufactures animal-free, highly bioactive and innovative proteins and growth factors for life science applications.
Catherine Elton, CEO of Qkine is an Accelerate@Babraham Alumni. We are delighted to hear about the success of Qkine!
To read more about the Accelerate@Babraham competition, including when applications open, visit the website: